Mannatech (NASDAQ:MTEX) Receives New Coverage from Analysts at StockNews.com

Analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a note issued to investors on Monday. The brokerage set a “buy” rating on the stock.

Mannatech Stock Down 0.1 %

Mannatech stock opened at $7.50 on Monday. The firm has a 50 day simple moving average of $7.35 and a 200 day simple moving average of $7.73. The company has a current ratio of 1.17, a quick ratio of 0.62 and a debt-to-equity ratio of 0.54. Mannatech has a 1-year low of $6.75 and a 1-year high of $11.80. The firm has a market capitalization of $14.14 million, a price-to-earnings ratio of -8.43 and a beta of 1.17.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%. The company had revenue of $27.74 million during the quarter.

Insider Activity

In other news, Director Larry A. Jobe sold 16,288 shares of the stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the sale, the director now directly owns 54,721 shares of the company’s stock, valued at $424,087.75. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 41.50% of the company’s stock.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.